prostate cancer
PET Imaging For Prostate Cancer
This video shows a presentation about PET imaging for prostate cancer. Video by Gerald L. Andriole, Jr., MD, the Robert K. Royce Distinguished Professor and Chief of Urologic Surgery at Barnes-Jewish...
Genetics and Biomarkers for Prostate Cancer and...
Alan H. Bryce, MD, Medical Director of the Genomic Oncology Clinic at Mayo Clinic Arizona in Scottsdale, discusses genetics and biomarkers for prostate cancer and bladder cancer. Genetic testing is now...
Updates in Focal Therapy of Prostate Cancer
Thomas J. Polascik, MD, FACS, Professor of Urology at Duke University Medical Center, discusses the effectiveness of focal therapy for prostate cancer as an alternative to radical therapy. He presents...
Real Life MoLEP Case Number 14: Patient In Retention...
This man was recently treated for a stone in a left ureterocoele and as a consequence developed refractory urinary retention. He was under active surveillance for ISUP grade I prostate cancer. We decided...
Updates in Screening: Prostate Cancer Guidelines
Gerald L. Andriole, Jr., MD, a Robert K. Royce Distinguished Professor and Chief of Urologic Surgery at Barnes-Jewish Hospital, the Siteman Cancer Center, and Washington University School of Medicine...
Prostate Cancer Genetic Risk Calculator 1.0
Joseph C. Presti, Jr., MD, FACS, Regional Leader of Urologic Oncology Surgery at Kaiser Permanente Northern California, discusses the development of Kaiser Permanente’s new prostate cancer risk calculator...
HIFU: The European Experience
Rafael Sanchez-Salas, MD, attending surgeon at L’Institut Mutualiste Montsouris in Paris, France, and a member of the Focal Therapy Society, discusses high-intensity focused ultrasound treatment (HIFU)...
Con: The Role of Currently Available Biomarkers...
Alan H. Bryce, MD, Chair of the Division of Hematology and Medical Oncology and Assistant Professor of Medicine at the Mayo Clinic in Phoenix, Arizona, argues that although germline testing is beneficial,...
Con: The Role of Currently Available Biomarkers...
Alan H. Bryce, MD, Chair of the Division of Hematology and Medical Oncology and Assistant Professor of Medicine at the Mayo Clinic in Phoenix, Arizona, argues that although germline testing is beneficial,...
Pro: The Role of Currently Available Biomarkers...
E. David Crawford, MD, Editor-in-Chief of Grand Rounds in Urology, argues that doctors need to do biomarker testing to know which patients to biopsy, follow closely, and treat with radiation. He discusses...